Kidney Cancer Journal | Volume 8, January – December 2024
Efficacy, Effectiveness, and Safety of Interventions for Von Hippel-Lindau Associated Renal Cell...
Read More
Select Page
Kidney Cancer Journal | Jan 2024
Efficacy, Effectiveness, and Safety of Interventions for Von Hippel-Lindau Associated Renal Cell...
Read MoreRichard E. Link, MD, PhD | Jan 2024
Richard E. Link, MD, PhD, discusses the shifting landscape of minimally invasive urologic surgery in the era of single-site robotics. He describes the state of urologic minimally invasive surgery as a “messy toolbox,” with a huge diversity of technologies and techniques currently employed and a lack of consensus.
Dr. Link then ranks approaches based on invasiveness, with robotic single-port (SP) systems being the least invasive. He outlines benefits and drawbacks of various techniques and wonders if there has been a period of stagnation.
He then addresses advantages of the da Vinci SP system, with a softball-sized working envelope and a 360-degree rotation around its axis, its robotic dexterity, its ability to work through small incisions (2.7 cm), and its versatility for multi-quadrant surgery, as well as in working with extraperitoneal, retroperitoneal, and transvesical approaches. He lists disadvantages as well, including cost, scarcity, learning curve, and challenges with large specimens.
Dr. Link contends that development of the SP approach is driving an increase in extraperitoneal approaches (while laparoscopic and robotic advancements drove towards the transperitoneal approaches). He then explains the shift towards the retroperitoneal approach, which is more efficient and timesaving. Dr. Link lists anesthesia advantages of SP, including shorter procedures, lower risk of abdominal entry vascular and organ complications, less pain, and fewer incisions.
Dr. Link then explains that today the SP comprises the vast majority of his radical prostatectomies. He describes the new technology interplay between cost/availability, skills/training, patient benefits, and versatility/speed and acknowledges the tension between a new platform and a technique with which a practitioner is comfortable. Dr. Link predicts that costs will drop, availability will rise, and calls SP “the future.”
Read MoreMark N. Painter, CPMA, MBS | Jan 2024
Mark N. Painter, CPMA, discusses the current landscape of telehealth in Urology, including billing and coding changes anticipated for 2024. Over the course of his presentation, Mr. Painter touches on:
Billing for Audio-Visual versus Audio-Only Visits
Private-Payer Telehealth Coverage
Urology-Specific Uses for Telehealth
Benefits of Telehealth for Patient and Physician
Potential Pitfalls of Telehealth in Urology
Mr. Painter concludes that supplementing traditional practice with telehealth is an overall benefit for physician, patient, and practice.
Read MoreDonald Baker, R.T.(R)(CT)(MR) | Dec 2023
Donald Baker, R.T.(R)(CT)(MR), discusses the advancements in prostate cancer detection, emphasizing the development and implementation of an integrated clinical solution. This comprehensive approach leverages state-of-the-art imaging technologies, combined with innovative diagnostic protocols, to improve the early detection and characterization of prostate cancer.
Baker discusses the importance of standardized imaging protocols using mpMRI and PET/CT scans to ensure consistency and reliability in prostate cancer detection. The adoption of these standards across clinical settings contributes to better patient management and treatment planning. In addition, Baker emphasizes the integration of artificial intelligence (AI) and machine learning algorithms into the diagnostic workflow.
Baker underscores the significance of multidisciplinary collaboration in the successful implementation of this integrated clinical solution. By bringing together expertise from radiology, urology, oncology, and medical physics, a more holistic approach to prostate cancer detection and management is achieved.
Read More